Jasper Therapeutics Inc

General ticker "JSPR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $333.3M

Jasper Therapeutics Inc follows the US Stock Market performance with the rate: 32.5%.

Estimated limits based on current volatility of 4.2%: low 20.66$, high 22.49$

Factors to consider:

  • Current price 111.9% above estimated high
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.52$, 10.44$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.87$, 7.95$]

Financial Metrics affecting the JSPR estimates:

  • Negative: Non-GAAP EPS, $ of -6.20 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -47.73 <= 2.35
  • Negative: negative Net income
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term JSPR quotes

Long-term JSPR plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $36.83MM $51.20MM $68.86MM
Operating Income $-36.83MM $-51.20MM $-68.86MM
Non-Operating Income $-6.16MM $13.51MM $2.77MM
R&D Expense $25.42MM $34.63MM $51.78MM
Income(Loss) $-42.99MM $-37.69MM $-66.09MM
Taxes $0.00MM $-13.51MM $-1.63MM
Profit(Loss) $-42.99MM $-24.17MM $-64.47MM
Stockholders Equity $69.52MM $35.99MM $78.44MM
Inventory $0.55MM $0.00MM $0.00MM
Assets $93.65MM $48.36MM $94.89MM
Operating Cash Flow $-33.68MM $-45.86MM $-52.07MM
Capital expenditure $2.43MM $0.58MM $0.27MM
Investing Cash Flow $-2.43MM $-0.58MM $-0.27MM
Financing Cash Flow $100.97MM $0.06MM $100.97MM
Earnings Per Share* $-21.05 $-6.63 $-6.18

* EPS are Split Adjusted, recent splits may be reflected with a delay.